Skip to main content
Menu
Close
Utility menu
Explore Funding Opportunities
Conduct Business with HJF
Find Your Career
Donate to HJF
Contact Us
Main navigation
Research Solutions
Contract Vehicles
Funding Opportunities
Proposal Support
Administration
Administering Subawards
Consulting & Vendor Contract Services
Licensing Technologies
Procuring Equipment
Leasing & Renovation
Program Support
Operations
Regulatory Compliance
IT Services
Graphics, Promotion, and Writing
Research Staff
Expertise
HJF and COVID-19
Technologies Available
The Veterans Metrics Initiative
What is Military Medicine?
About HJF
Learn About HJF
HJF Leadership
News
Events
Media Resources
FY23 Impact Report
Main navigation
Research Solutions
Contract Vehicles
Funding Opportunities
Proposal Support
Administration
Administering Subawards
Consulting & Vendor Contract Services
Licensing Technologies
Procuring Equipment
Leasing & Renovation
Program Support
Operations
Regulatory Compliance
IT Services
Graphics, Promotion, and Writing
Research Staff
Expertise
HJF and COVID-19
Technologies Available
The Veterans Metrics Initiative
What is Military Medicine?
About HJF
Learn About HJF
HJF Leadership
News
Events
Media Resources
FY23 Impact Report
Utility Menu
Explore Funding Opportunities
Conduct Business with HJF
Find Your Career
Donate to HJF
Contact Us
News Article
September 24, 2019
HIV Vaccine Trial Marks 10 Years of Progress
HIV Vaccine Trial Marks 10 Years of Progress
HIV Vaccine Trial Marks 10 years of Progress.
Case Study
1995-04-01
RespiGam and Synagis
1995-04-01
RespiGam and Synagis
HJF paved the way for two important therapies that help save the lives of thousands of infants at risk for RSV infection every year. The story of this successful collaboration that produced the FDA
Read More
The appearance of the U.S. Department of Defense (DoD) visual information does not imply or constitute DoD endorsement.
©2024 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. All rights reserved.
Bottom Bar
Privacy Policy